ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CDNA CareDx Inc

14.90
3.84 (34.72%)
11 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
CareDx Inc NASDAQ:CDNA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.84 34.72% 14.90 5.00 15.90 15.30 12.5301 12.63 2,494,807 05:00:14

CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference

27/02/2024 9:05pm

Business Wire


CareDx (NASDAQ:CDNA)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more CareDx Charts.

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company will be participating in the upcoming Raymond James & Associates’ 45th Annual Institutional Investors Conference.

CareDx’s management is scheduled to present on Wednesday, March 6, 2024, at 9:50 a.m. Eastern Standard Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at investors.CareDx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit www.CareDx.com.

CareDx, Inc. Media Relations Anna Czene 818-731-2203 aczene@caredx.com

Investor Relations Greg Chodaczek investor@caredx.com

1 Year CareDx Chart

1 Year CareDx Chart

1 Month CareDx Chart

1 Month CareDx Chart

Your Recent History

Delayed Upgrade Clock